Concepedia

Natacha Stoehr

NS

9

Publications

2K

Citations

9

H-Index

1999

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Catania

Novartis Institutes for BioMedical Research

Friedrich Miescher Institute

Natacha Stoehr is an author at Novartis (Switzerland) specializing in medicine, neuroscience, and pharmacology.

Top concepts

Publications per year

1999–2016

9

Publications

9

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations

, , +7

CPCCOEt, a Noncompetitive Metabotropic Glutamate Receptor 1 Antagonist, Inhibits Receptor Signaling Without Affecting Glutamate Binding

Stephane Litschig, F. Gasparini, D Rueegg et al. · Molecular Pharmacology · 1999 · 342 citations

The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors

Adriana Pagano, Doris Rüegg, Stephane Litschig et al. · Journal of Biological Chemistry · 2000 · 267 citations · Full text

A selective metabotropic glutamate receptor 7 agonist: Activation of receptor signaling via an allosteric site modulates stress parameters<i>in vivo</i>

Kayo Mitsukawa, Rina Yamamoto, Silvio Ofner et al. · Proceedings of the National Academy of Sciences · 2005 · 234 citations · Full text

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function

Katherine Walker, M. Bowes, Moh Panesar et al. · Neuropharmacology · 2001 · 165 citations

, , +7

Rows per page

1–5 of 9